Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term oncogenes. Found 14 abstracts

Anari F, Ramamurthy C, Zibelman M. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer. Future Oncol. 2018 Jun;14(14):1409-21.
Araiza-Olivera D, Chernoff J. Hras helps hippo heterodimerize to evade tumor suppression. Small GTPases. 2018 Jul 04;9(4):327-31.   PMCID: PMC5997136
Malouf GG, Tahara T, Paradis V, Fabre M, Guettier C, Yamazaki J, Long H, Lu Y, Raynal NJ, Jelinek J, Mouawad R, Khayat D, Brugieres L, Raymond E, Issa JP. Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features. Epigenetics. 2015 Sep 02;10(9):872-81.
Ivanov SV, Miller J, Lucito R, Tang CL, Ivanova AV, Pei JM, Carbone M, Cruz C, Beck A, Webb C, Nonaka D, Testa JR, Pass HI. Genomic events associated with progression of pleural malignant mesothelioma. International journal of cancer. 2009 Feb;124(3):589-99.   PMCID: PMC2933144
Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005 Nov 14;24(50):7455-64.
Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, Testa JR, Peifley KA, Winkles JA. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. American Journal of Pathology. 2000 Apr;156(4):1253-61.
Shafarenko M, Mahler J, Cochran C, Kisielewski A, Golding E, Wiseman R, Goodrow T. Similar incidence of K-ras mutations in lung carcinomas of FVB/N mice and FVB/N mice carrying a mutant p53 transgene. Carcinogenesis. 1997 Jul;18(7):1423-6.
Moscatello DK, Holgadomadruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW, Biegel JA, Hayes RL, Wong AJ. Frequent Expression of a Mutant Epidermal Growth-Factor Receptor in Multiple Human Tumors. Cancer Research. 1995 Dec;55(23):5536-9.
Goodrow TL, Nichols WW, Storer RD, Anderson MW, Maronpot RR. Activation of H-Ras Is Prevalent in 1,3-Butadiene-Induced and Spontaneously Occurring Murine Harderian-Gland Tumors. Carcinogenesis. 1994 Nov;15(11):2665-7.
Testa JR, Getts LA, Salazar H, Liu ZM, Handel LM, Godwin AK, Hamilton TC. Spontaneous Transformation of Rat Ovarian Surface Epithelial- Cells Results in Well to Poorly Differentiated Tumors with a Parallel Range of Cytogenetic Complexity. Cancer Research. 1994 May 15;54(10):2778-84.
Berek JS, Martinezmaza O, Hamilton T, Trope C, Kaern J, Baak J, Rustin GJ. Molecular and Biological Factors in the Pathogenesis of Ovarian-Cancer. Annals of Oncology. 1993 Jan;4:3-16.
Knudson AG. Pediatric Molecular Oncology - Past as Prologue to the Future. Cancer. 1993 May 15;71(10):3320-4.
Knudson Jr AG. Pediatric molecular oncology: Past as prologue to the future. Cancer. 1993 Jan;71(10 SUPPL.):3320-4.
Aldaz CM, Chen A, Gollahon LS, Russo J, Zappler K. Nonrandom Abnormalities Involving Chromosome-1 and Harvey-Ras-1 Alleles in Rat Mammary-Tumor Progression. Cancer Research. 1992 Sep;52(17):4791-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term oncogenes

oncogenes cancer tumor suppressor genes gene prevention mutations pediatric cancer tumor suppressors causation carcinomas amplification transgenic mice treatment copy number alterations AKT breast cancers LUNG-CANCER b6c3f1 mice sequencing analysis immunohistochemical cell-line protein-kinase-b transformation PKB kinases hormone epithelial-cells frequent activation GENE-EXPRESSION activation retinoblastoma exposure human-breast rats tissues oncogene amplification responsiveness small GTpases fibrolamellar carcinoma growth-factor proto- DNA methylation induced apoptosis wilms tumor carcinoembryonic antigen etiology neu signal transduction her-2 MICROARRAY ANALYSIS flow cytometric analysis dna-sequences inhalation toxicity myc protooncogene chromosome-aberrations murine sarcoma-virus prognostic dimerization human-breast cancer growth n-nitrosomethylurea inhibits growth-factor-alpha mouse-liver ha-ras significance constitutive production akt mesothelioma CGH hepatectomy EXPRESSION phosphatidylinositol 3-kinase apoptosis partially methylated domains genetic disorder f1-mice tumor-necrosis-factor tuberous-sclerosis immunotherapy tumor suppressor gene cytokine molecular oncology tumor-antigen next-generation sequencing N-CADHERIN HUMAN-CHROMOSOME 3P213 biomarkers c-myc deletion Line-1 human malignancy PROGNOSTIC-FACTORS mutation ovarian cancer dna-ploidy ovarian-cancer heterozygosity tumor-cell growth human glioma xenografts n-myc human pancreatic-cancer prostate intraepithelial neoplasia cellular dna content cytotoxic agent oncogene hippo differential display risk-factors sequence factors TUMOR-SUPPRESSOR stage-i ARRAY-CGH DATA cytokine production HOMOZYGOUS DELETION REGION carcinogenicity targeted therapy mouse childhood cancer skin carcinogenesis ONCOSTATIN-M prognostic- detection ROMA
Last updated on Friday, December 06, 2019